Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.35 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.34 |
| ▸ | F9 | P00740 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | TNKS | O95271 | 2/20 | 0.32 |
| ▸ | TNKS2 | Q9H2K2 | 2/20 | 0.32 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.31 |
| ▸ | PRKDC | P78527 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.30 |
| ▸ | GRM5 | P41594 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22960402 | 0.92 | ALOX5 (0.36) | ALOX5MAPTRXFP1LIMK1TP53 | |
| SCHEMBL22960405 | 0.91 | MAPT (0.37) | ALOX5MAPTRXFP1LIMK1TP53 | |
| SCHEMBL17341561 | 0.90 | ALOX5 (0.34) | ALOX5MAPTRXFP1F9TP53 | |
| SCHEMBL22960418 | 0.89 | MAPT (0.36) | MAPTRXFP1LIMK1TP53KDM4E | |
| SCHEMBL23309006 | 0.89 | ALOX5 (0.44) | ALOX5MAPTRXFP1TP53PRKDC | |
| SCHEMBL17464042 | 0.88 | MAPT (0.41) | ALOX5MAPTRXFP1TP53KDM4E | |
| SCHEMBL22960404 | 0.87 | PRKDC (0.34) | ALOX5MAPTRXFP1TP53PRKDC | |
| SCHEMBL19985917 | 0.87 | KDM4E (0.35) | ALOX5MAPTRXFP1LIMK1TP53 | |
| SCHEMBL19985933 | 0.87 | KDM4E (0.35) | ALOX5MAPTRXFP1LIMK1TP53 | |
| SCHEMBL18505626 | 0.86 | MAPT (0.34) | MAPTRXFP1TP53KDM4EATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230134923-A1 | ORGANIC MATERIAL COMPOSITION AND APPLICATIONS THEREOF | NINGBO LUMILAN ADVANCED MATERIALS CO., LTD. (CN) | 2023-05-04 | — | — | US | disclosed |
| US-20230134923-A1 | ORGANIC MATERIAL COMPOSITION AND APPLICATIONS THEREOF | NINGBO LUMILAN ADVANCED MATERIALS CO., LTD. (CN) | 2023-05-04 | — | — | US | disclosed |
| US-20210336153-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND, A PLURALITY OF HOST MATERIALS, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | ROHM & HAAS ELECT MATERIALS KOREA LTD (KR) | 2021-10-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230134923-A1 | ORGANIC MATERIAL COMPOSITION AND APPLICATIONS THEREOF | PIEZO1, VCL, VDAC3 | ALOX5 977/4885MAPT 940/4885RXFP1 4860/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.